Is retroelement-based gene editing a safer alternative to CRISPR-Cas approaches?

In a Perspective, Stephen Tang and Samuel Sternberg discuss retroelement-based gene editing as a safer alternative to CRISPR-Cas approaches.

Explore the clinical tools that use race to steer care

Every day, physicians use clinical algorithms to make decisions about the patients in their exam rooms. To help weigh a patient’s surgical risk or likelihood

September 3, 2024

How Exact Sciences’ out-of-the-box thinking convinced Americans to try Cologuard’s colorectal cancer screening test

What do an animated cardboard box, a famously relatable celebrity journalist and the PGA Tour have in common? They’re all part of Exact Sciences’ marketing

August 16, 2023

Younger Adults Are Going Public With Their Digestive Problems

Lauren Bell was stressed out and just starting her first job post-college in New York City when she realized a bout of food poisoning wasn’t

August 6, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.